Jul 30, 2026 Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026 Learn More
Jul 15, 2026 Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers Learn More
Jun 1, 2026 Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting Learn More
May 14, 2026 Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates Learn More